NEW YORK, July 29 - Parallele BioScience and Baylor College of Medicine are collaborating on genetic studies of SNPs for certain congenital heart abnormalities, Parallele said today.
Under the agreement, Parallele will work with John Belmont of Baylor's cardiovascular genetics clinic, using its SNP genotyping technology to scan candidate genes for mutations for left ventricular outflow tract obstruction, a group of heart abnormalities that can either lead to death in newborns or cause heart valve infections or degenerations later on, the company said.
ParAllele will design custom reagents for the experiments, and will use over a thousand samples from patients and families that Baylor researchers have collected.
The project is being funded by an NIH grant awarded to Baylor.
ParAllele and Baylor have also collaborated on the International HapMap project.